Innbiotec Pharma researches, produces and offers innovative biomedical solutions for the well-being of people.
The company was originally founded in 2015 as a spin-off of the Department of Molecular Biology of the Faculty of Medicine of the University of Florence to enhance biotechnologies developed in 15 years of research. After a multi-year development phase conducted with its internal team and in constant collaboration with Italian and international universities, in 2020 Innbiotec began selling its products to the Italian and foreign market.
Innbiotec uses natural ingredients and innovative compounds with proven clinical validity to give life to new molecules and products with efficacy proven by numerous internal studies, years of scientific research and multiple patents.
The company currently offers more than 20 products on the market across three lines: CAREiNN, the nutraceutical food supplements line for the wellbeing of people; DERMAiNN, the cosmetics line; and ACTIVEiNN, the sport supplements line for increased performance and post-workout recovery.
Innbiotec constantly continues its scientific research and is carrying out clinical trials for three high impact applications: neurodegeneration (Alzheimer's and Senile dementia); advanced respiratory disorders (Covid-19 and acute pneumonia); and liver diseases (non-alcoholic fatty liver disease / NAFLD and non-alcoholic steatohepatitis / NASH).